Key result
Metabolic syndrome is linked to lower low-frequency HRV in postmenopausal women.
Why the study?
This study aimed to investigate the association between metabolic syndrome and autonomic nervous system activity in middle-aged postmenopausal women and explore heart rate variability as a marker for early diagnosis.
Is metabolic syndrome associated with reduced autonomic nervous system activity in middle-aged postmenopausal women?
Cross-Sectional (n=276)
No
Is metabolic syndrome associated with reduced autonomic nervous system activity in middle-aged postmenopausal women?
Reduced heart rate variability, particularly in the low-frequency domain, is associated with metabolic syndrome and higher fasting blood glucose in postmenopausal women, suggesting its potential utility as an early physiological marker.
Should not yet change practice; leaves open LF index as hypothesis-generating marker of autonomic changes in postmenopausal metabolic syndrome.
Purpose: This study aimed to investigate the association between metabolic syndrome and autonomic nervous system activity in middle-aged postmenopausal women. In addition, it explored the clinical applicability of heart rate variability (HRV) as a physiological marker for the early diagnosis and management of metabolic disorders.Methods: This study was conducted as a secondary data analysis using health examination data. The dataset included 276 postmenopausal women aged 50 to 65 years. Autonomic nervous system activity was evaluated using HRV indices, including standard deviation of the normal-to-normal interval (SDNN), total power (TP), low frequency (LF), and high frequency (HF). Statistical analyses were performed using the t-test, chi-square test, and Pearson correlation analysis with SPSS version 26.0.Results: The prevalence of metabolic syndrome among the participants was 21.4%. The LF index was significantly lower in the metabolic syndrome group compared with the normal group (t = 2.74, p = .007). Additionally, fasting blood glucose showed significant negative correlations with SDNN (r = -.16, p = .010), TP (r = -.21, p < .001), LF (r = -.17, p = .004), and HF (r = -.18, p = .003).Conclusion: A reduction in HRV, particularly in LF, may serve as an indicator of metabolic syndrome in postmenopausal women. Because autonomic dysfunction can potentially be improved through nursing interventions, the use of HRV-based monitoring and personalized nursing strategies should be considered in clinical practice to help prevent the onset of metabolic syndrome in postmenopausal women.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) conducted a cross-sectional in Metabolic syndrome (n=276). Metabolic syndrome vs. Non-metabolic syndrome was evaluated on Low frequency (LF) index of heart rate variability (p=.007). Postmenopausal women with metabolic syndrome had a significantly lower low frequency (LF) index of heart rate variability compared to those without metabolic syndrome (4.34 vs 4.69, p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: